Rui Yun

Improved Efficacy of a Tolerizing DNA Vaccine for Reversal of Hyperglycemia through Enhancement of Gene Expression and Localization to Intracellular Sites

H. Garren, L. Steinman, G. Eisenbarth, 2008, The Journal of Immunology.

Association of 5-lipoxygenase gene polymorphisms with bronchial asthma

Rui Yun, Chunying Bai, Tiewei Shi, 2012, Experimental and therapeutic medicine.

Eco Friendly Fabrication of Gold Nanoclusters and Their Induction of Cardiomyocyte Apoptosis After Intratracheal Instillation in Rats

Rui Yun, Xiao-qiang Cong, Xiangxiang Zhang, 2019, Journal of Cluster Science.

Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma

F. Zhan, B. Barlogie, J. Shaughnessy, 2009, Molecular Cancer Therapeutics.

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways

Michael D. Robbins, D. Chao, G. Starling, 2014, Cancer Immunology, Immunotherapy.

Abstract 255: Dual targeting of Delta-like ligand 4 (DLL4) and programmed death 1(PD1) inhibits tumor growth and generates enhanced long-term immunological memory

J. Lewicki, A. Gurney, T. Hoey, 2015 .

Natural killer (NK) cell activation, cytokine production, and cytotoxicity in human PBMC/myeloma cell co-culture exposed to elotuzumab (Elo) alone or in combination with lenalidomide (Len).

G. Starling, A. Rice, Rui Yun, 2012 .